Biomedical Synergies, Inc. was founded by tissue and blood banking experts who offer unparalleled subject matter expertise to augment their software application, a critical differentiation in the marketplace today. One of the founders of BSI, who has contributed much of the intellectual property into the software, is Duke Kasprisin, M.D. Dr. Kasprisin is the past President of the American Association of Tissue Banks (AATB) and was formerly the Chief Medical Officer of the American Red Cross Transplantation Services. BSI's proven tissue tracking software and business practices assist hospitals with biologic and non-biologic implant product issues, regulatory compliance questions and process inquiries. BSI partners with facilities to develop compliance infrastructure through Standard Operating Procedures (SOPs), proper organizational structure and software that is designed to increase patient safety, reduce risk and streamline workflows.
Chairman and CEO of Global Med Technologies, Inc., Michael I. Ruxin, M.D., stated, "We are pleased to partner with Biomedical Synergies and their extraordinary team. As a leading provider of blood banking software and services, Global Med has seen first hand the expansion of the blood bank's responsibility for the administration and oversight of human tissue and cellular therapy products. To meet the needs of our customers worldwide, Global Med will now offer an additional mechanism to decrease the liability for hospitals and accomplish tissue/implant tracking management more effectively and expeditiously."
Dr. Ruxin continued, "Global Med's strategy to expand its offerings and grow our revenue base through a mutually beneficial partnership is a win-win for Biomedical Synergies, our customers and the Global Med Family of Companies."
|SOURCE Global Med Technologies(R), Inc.|
Copyright©2008 PR Newswire.
All rights reserved